首页> 外文期刊>Journal of animal and veterinary advances >Pharmacokinetic and Metabolic Profile of Difloxacin in Camels Following Parenteral Administration
【24h】

Pharmacokinetic and Metabolic Profile of Difloxacin in Camels Following Parenteral Administration

机译:胃肠外给药后骆驼中地氟沙星的药代动力学和代谢谱

获取原文
       

摘要

The pharmacokinetics of difloxacin delivered by both Intravenous (IV) and Subcutaneous (SC) routes and its metabolic profile and elimination pattern following the subcutaneous administration of 5 mg kg-1 were investigated in a crossover study using 10 camels (Camelus dromedaries). Multiple plasma, faecal and urine samples were collected for the quantitation of difloxacin and its metabolites using HPLC with fluorescence detection and mass spectrometry for the elucidation of metabolite structure. Difloxacin was eliminated from plasma with elimination half-lives of 6.65 and 7.52 h following Intravenous (IV) and Subcutaneous (SC) administration, respectively. The drug was absorbed slowly following SC administration and a maximum concentration of 2.1 μg mL-1 was attained at (Tmax) 4 h with a bioavailability of 94.6%. Difloxacin was metabolised in camels by the N-demethylation pathway to produce the active metabolite sarafloxacin (M1) and by oxidation into three other metabolites, 3-oxosarafloxacin (M2), 3-oxodifloxacin (M3) and desethylenesarafloxacin (M4). The concentrations of the circulating Metabolites in plasma (M1, M2 and M3) were much lower than that of the parent drug. The administered dose of difloxacin was eliminated largely in its parent form in faeces (69.5%) and to a small extent in urine (5.9%) whereas sarafloxacin (M1) and 3-oxosarafloxacin (M2) were the main metabolites detected in faeces (7.2 and 3%) and urine (3.5 and 1.8%). The other metabolites, 3-oxodifloxacin (M3) and desethylenesarafloxacin (M4) were detected to a minimal extent in faeces only and amounted to 1.47 and 0.6% of the dose, respectively. The results of the present study revealed that the N-demethylation and oxidative pathways of biotransformation are the primary routes of difloxacin metabolism in camels with renal and hepatobiliary excretion through urine and faeces. Phase II conjugation plays a minor role in the elimination of the drug in camels.
机译:在一项使用10头骆驼(骆驼驼)的交叉研究中,研究了静脉(IV)和皮下(SC)途径递送的地氟沙星的药代动力学及其皮下给药5 mg kg-1后的代谢特征和消除模式。收集多个血浆,粪便和尿液样品,使用HPLC荧光检测和质谱法定量地氟沙星及其代谢物,以阐明代谢物的结构。静脉(IV)和皮下(SC)给药后,地氟沙星从血浆中消除,消除半衰期分别为6.65和7.52小时。 SC给药后药物吸收缓慢,在(Tmax)4 h达到最大浓度为2.1μgmL-1,生物利用度为94.6%。地氟沙星通过N-去甲基化途径在骆驼中代谢,产生活性代谢物沙拉沙星(M1),并氧化成其他三种代谢物,3-氧杂氟西沙星(M2),3-氧二氟沙星(M3)和去乙烯沙拉沙星(M4)。血浆中循环代谢物(M1,M2和M3)的浓度远低于母体药物。地氟沙星的排泄剂量以其母体形式在粪便中被消除(69.5%),并在尿液中少量地被消除(5.9%),而沙拉沙星(M1)和3-氧杂氧氟沙星(M2)是粪便中检测到的主要代谢物(7.2)和3%)和尿液(3.5和1.8%)。仅在粪便中检测到最小程度的其他代谢物3-氧二氟沙星(M3)和去乙烯沙罗沙星(M4),分别占剂量的1.47和0.6%。本研究的结果表明,生物转化的N-去甲基化和氧化途径是地氟沙星代谢的主要途径,骆驼通过尿液和粪便排泄了肾脏和肝胆。 II期缀合在消除骆驼中的药物方面起着较小的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号